Fierce Pharma: Meeting the commercialization challenge of a surging gene and cell therapy market

FierceBiotech

Undaunted by the challenges the COVID-19 pandemic unleashed on the world the expected surge of cell and gene therapies already in the pipeline and on the horizon will continue to materialize, and with them the complexity of riding that wave of innovation.
Working together to alleviate barriers

Cell and gene therapy solutions

Working together to alleviate barriers
When healthcare advances, so must the processes to connect patients to the therapies they need. And because a rapidly changing cell and gene therapy industry requires an equally innovative partner, AmerisourceBergen is committed to delivering solutions that enable this connection.

Let’s build the future together. 
Working together to alleviate barriers